On Friday, Shares of International Business Machines Corp. (NYSE:IBM), lost - 2.50% to $148.85.
International Business Machines Corp., announced general availability and improvements to a set of services for IBM’s platform-as-a-service (PaaS), Bluemix that enable developers to more seamlessly integrate Java-based resources into their cloud-based applications.
The new IBM Cloud tools are designed to assist developers broaden the capabilities of their applications to give users a more robust cloud experience, by leveraging added security and flexibility to use a vast array of resources for their development. They comprise:
- Liberty Buildpack updated the Liberty runtime to make accessible or preview the latest Java EE 7 Liberty features, and while IBM JRE 7.1 remains the default it is now possible to test and run applications in Bluemix with Java 8. Additionally, among other improvements, the jsp-2.3, el-3.0, and jdbc-4.1 Liberty features, formerly in beta, are now accessible as production-ready.
- IBM Eclipse Tools for Bluemix is launched with a new version that now comprises JavaScript Debug, support for Node.js applications, Java 8 Liberty for Java integration, Eclipse Mars support for the latest Eclipse Mars version in addition to an improved trust self-signed certificates capability. Additionally, incremental publish support for JEE applications has been expanded to support web fragment projects.
- XPages on IBM Bluemix brings the power of Domino XPages to the cloud, allowing developers to create feature-rich, responsive, and secure applications that can be quickly brought to market on Bluemix.
International Business Machines Corporation provides information technology (IT) products and services worldwide. The company’s Global Technology Services segment provides IT infrastructure and business process services, such as outsourcing, processing, integrated technology, cloud, and technology support.
Shares of Nexstar Broadcasting Group, Inc. (NASDAQ:NXST), declined -3.40% to $47.41, during its last trading session.
Nexstar Broadcasting Group declared that the Company intends to act on the Board of Directors’ authorization to repurchase up to $100 million of its Class A common stock.
Perry A. Sook, Chairman, President and Chief Executive Officer of Nexstar Broadcasting Group, Inc. commented, “The repurchase authorization reflects our confidence in the Company’s growing free cash flow from operations based on visible organic growth opportunities and provides a flexible complement to our existing return of capital initiatives through our quarterly cash dividend. We believe the $100 million share repurchase authorization, which at Friday’s closing price represents about 2 million shares, is a prudent use of capital as Nexstar is on pace to achieve its projected pro-forma free cash flow of about $456 million during the 2015/2016 cycle, or average pro-forma free cash flow of about $7.30 per share per year.
Nexstar Broadcasting Group, Inc. operates as a television broadcasting and digital media company in the United States. It focuses on the acquisition, development, and operation of television stations and interactive community Websites in medium-sized markets.
Finally, Relypsa Inc (NASDAQ:RLYP), remained flat at $23.75.
Relypsa, declared that on August 17, 2015, the compensation committee of the company’s board of directors granted eight new employees options to purchase an aggregate of 51,500 shares of the company’s common stock with a per share exercise price of $25.27, the closing trading price on the grant date. In addition, on December 15, 2014, the compensation committee of the company’s board of directors granted six new employees options to purchase an aggregate of 41,800 shares of the Company’s common stock with a per share exercise price of $32.99, the closing trading price on the grant. The stock options were granted following the Relypsa, Inc. 2014 Employment Commencement Incentive Plan, which was approved by the company’s board of directors in June 2014 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the company.
Relypsa, Inc., a biopharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
